Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a double blind, phase III randomized clinical trial in healthy Serbian adults

This study was a phase III, multicenter, double-blind, randomized, placebo-controlled trial to evaluate the safety and immunogenicity of a seasonal trivalent split, inactivated influenza vaccine (TIV) in healthy Serbian adults between the ages of 18 and 65 years. This egg-based vaccine was manufactu...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ther Adv Vaccines Immunother
Главные авторы: Stevanovic, Goran, Obradovic, Aleksandar, Ristic, Snezana, Petrovic, Dragan, Milenkovic, Branislava, Mitrovic, Danilo, Vignjevic, Svetlana Filipovic, Ilic, Katarina, Stoiljkovic, Vera, Lavadinovic, Lidija, Pelemis, Mijomir, Petrovic, Svetlana, Vidmanic, Ana, Popovic, Olga, Eremic, Natasa, Sparrow, Erin, Torelli, Guido, Socquet, Muriel, Holt, Renée, Ilieva-Borisova, Yordanka, Tang, Yuxiao, Scorza, Francesco Berlanda, Flores, Jorge, Rathi, Niraj
Формат: Artigo
Язык:Inglês
Опубликовано: SAGE Publications 2020
Предметы:
Influenza Vaccine Technologies: Successes, Challenges and Future Priorities
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7252356/
https://ncbi.nlm.nih.gov/pubmed/32518891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2515135520925336
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы